Weight-loss drugs like Ozempic have undoubtedly made their mark on healthcare. But they have also begun to shape the broader economy.While there are those “salivating at the prospect of where AI can go in the years ahead,” perhaps the “bigger leap in the near term” is the “technological miracle that is stopping us salivating at all,” Jim Reid, the global head of macro and thematic strategy at Deutsche Bank, said in a commentary. Perhaps the GLP-1 is the “real short-term general-purpose technology for a wider range of consumers, especially in the U.S." In other words, the age of the Ozempic economy has arrived. These are some of the ways you might feel the impact.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Join 350,000+ subscribers and keep yourself informed with a selection of
